Issue 20, 2013

Drug delivery by a self-assembled DNA tetrahedron for overcoming drug resistance in breast cancer cells

Abstract

A DNA tetrahedron is employed for efficient delivery of doxorubicin into drug-resistant breast cancer cells. The drug delivered with the DNA nanoconstruct is considerably cytotoxic, whereas free doxorubicin is virtually non-cytotoxic for the drug-resistant cells. Thus, the DNA tetrahedron, made of the inherently natural and biocompatible material, can be a good candidate for the drug carrier to overcome MDR in cancer cells.

Graphical abstract: Drug delivery by a self-assembled DNA tetrahedron for overcoming drug resistance in breast cancer cells

Supplementary files

Article information

Article type
Communication
Submitted
24 Aug. 2012
Accepted
18 Jan. 2013
First published
21 Jan. 2013

Chem. Commun., 2013,49, 2010-2012

Drug delivery by a self-assembled DNA tetrahedron for overcoming drug resistance in breast cancer cells

K. Kim, D. Kim, T. Lee, J. Y. Yhee, B. Kim, I. C. Kwon and D. Ahn, Chem. Commun., 2013, 49, 2010 DOI: 10.1039/C3CC38693G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements